Product Program year 2022 Source: CMS Open Payments

AngioVue

Device Optometry

General payments

$345,385

91 payments

Research payments

0 payments

Through program year 2022, $345,385 in general payments and $0 in research payments were reported against AngioVue (Optometry).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows

General

’19 ’20 ’21 ’22

Peak $205K

Year	Kind	Amount	Payments
2022	General	$24,475	7
2021	General	$57,671	20
2020	General	$58,480	18
2019	General	$204,759	46

Breakdown

Who paid General payments · program years 2019–2022

Optovue, Inc. $320,910 84 payments
Visionix USA, Inc $24,475 7 payments

Top recipients General payments · program year 2022

David Sarraf Ophthalmology · Los Angeles, CA $9,000 37% · 1 payment
Richard Rosen Ophthalmology · New York, NY $6,000 25% · 1 payment
Gregory Caldwell Optometrist · Duncansville, PA $4,475 18% · 2 payments
Michael Cymbor Optometrist · State College, PA $4,000 16% · 1 payment
Julie Rodman Optometrist · Fort Lauderdale, FL $1,000 4% · 2 payments

Each share is of general payments naming this product in 2022.

Specialties paid General payments · program year 2022

Ophthalmology $15,000 61% · 2 practitioners
Optometrist $9,475 39% · 3 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022

California $9,000 37% · 1 recipient
Pennsylvania $8,475 35% · 2 recipients
New York $6,000 25% · 1 recipient
Florida $1,000 4% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

Records

91 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.